Compare CGO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGO | ENLV |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.4M | 149.0M |
| IPO Year | 2004 | 2014 |
| Metric | CGO | ENLV |
|---|---|---|
| Price | $13.00 | $0.65 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 21.6K | ★ 309.9K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | ★ 9.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.71 | $0.43 |
| 52 Week High | $14.20 | $7.64 |
| Indicator | CGO | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 51.30 | 24.70 |
| Support Level | $12.96 | $0.43 |
| Resistance Level | $13.60 | $1.26 |
| Average True Range (ATR) | 0.26 | 0.13 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 59.02 | 2.11 |
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.